Status:
COMPLETED
Detecting Lung Cancer Based on Exhaled Breath
Lead Sponsor:
Peking University People's Hospital
Collaborating Sponsors:
Beijing Haidian Hospital
Aerospace 731 Hospital
Conditions:
Carcinoma
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Early detection is critical to improve the overall survival of lung cancer. Endogenous volatile organic compounds (VOCs) can be derived from many different metabolic pathways. On the other hand, cance...
Detailed Description
Endogenous volatile organic compounds (VOCs) can be derived from many different metabolic pathways. VOCs can be transported to the alveoli through the blood circulation and expelled by exhalation. Cha...
Eligibility Criteria
Inclusion
- Inclusion Criteria for inpatient :
- pulmonary nodules in competed tomography images
- plan to receive thoracic surgery
- Inclusion Criteria for controls :
- have planned physical examination every year
- plan to receive low-dose computed tomography
- Exclusion Criteria:
- history of malignant tumors.
- receive anti-tumor treatment such as radiotherapy, chemotherapy, targeted therapy before surgery
- with infections or liver disease
Exclusion
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
2236 Patients enrolled
Trial Details
Trial ID
NCT04419207
Start Date
March 1 2019
End Date
January 31 2022
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044